Evolus (EOLS) vs MapLight Therapeutics (MPLT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Evolus is the larger company by market cap ($515.2 million vs $508.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EOLS | MPLT |
|---|---|---|
| Share price | $7.80 | $9.15 |
| Market cap | $515.19M | $508.52M |
| 1-day change | +0.78% | -2.24% |
| YTD return | +16.39% | -46.71% |
| 1-year return | +23.64% | — |
| 5-year return | +0.91% | — |
| Forward P/E | 26.67 | — |
| EPS (TTM) | $-0.53 | $-6.25 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.31 | $40.43 |
| 52-week low | $3.86 | $8.92 |
| Distance from 52-week high | -16.22% | -77.37% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +92.31% | +190.05% |
| Average volume | 896.67K | 858.68K |
| Shares outstanding | 66.05M | 52.85M |
| Employees | 353 | 133 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Evolus
EOLS stock →Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults; and Evolysse, a collection of injectable hyaluronic acid gels, which includes various products, such as mid face, nasolabial folds, lips and eyes.
Health Care · Biotechnology: Pharmaceutical Preparations · 353 employees
About MapLight Therapeutics
MPLT stock →MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders.
Health Care · Biotechnology: Pharmaceutical Preparations · 133 employees
EOLS vs MPLT FAQ
Which is bigger, Evolus or MapLight Therapeutics?
Evolus (EOLS) is larger, with a market capitalization of $515.19M compared with $508.52M for MapLight Therapeutics (MPLT).
Are Evolus and MapLight Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.